Effect of ligand density, receptor density, and nanoparticle size on cell targeting
about
Drug carrier interaction with blood: a critical aspect for high-efficient vascular-targeted drug delivery systemsTargeted nanotechnology for cancer imaging.Multifunctional nanoparticles: cost versus benefit of adding targeting and imaging capabilitiesVascular targeting of nanocarriers: perplexing aspects of the seemingly straightforward paradigmUnderstanding Peptide Oligomeric State in Langmuir Monolayers of Amphiphilic 3-Helix Bundle-Forming Peptide-PEG Conjugates.Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology.Nanogel Carrier Design for Targeted Drug DeliveryNanotechnology for cancer treatment.Bioorthogonal Oxime Ligation Mediated In Vivo Cancer Targeting.Synthetic Strategies for Engineering Intravenous Hemostats.Integrated nanotechnology platform for tumor-targeted multimodal imaging and therapeutic cargo releaseLiver-targeted antiviral peptide nanocomplexes as potential anti-HCV therapeuticsAddressing challenges of heterogeneous tumor treatment through bispecific protein-mediated pretargeted drug delivery.Nanoconjugation of PSMA-Targeting Ligands Enhances Perinuclear Localization and Improves Efficacy of Delivered Alpha-Particle Emitters against Tumor Endothelial AnaloguesReduction of nanoparticle avidity enhances the selectivity of vascular targeting and PET detection of pulmonary inflammation'Living' PEGylation on gold nanoparticles to optimize cancer cell uptake by controlling targeting ligand and charge densities.Sortase-tag expressed protein ligation: combining protein purification and site-specific bioconjugation into a single step.Enhanced Human Epidermal Growth Factor Receptor 2 Degradation in Breast Cancer Cells by Lysosome-Targeting Gold Nanoconstructs.Rigid nanoparticle-based delivery of anti-cancer siRNA: challenges and opportunities.Working together: interactions between vaccine antigens and adjuvants.Recent advances in surface chemistry strategies for the fabrication of functional iron oxide based magnetic nanoparticles.Synthesis and functionalisation of magnetic nanoparticles for hyperthermia applications.Guiding principles in the design of ligand-targeted nanomedicines.Receptor-targeted drug delivery: current perspective and challenges.Targeted endothelial nanomedicine for common acute pathological conditions.Censored at the Nanoscale.Targeted PRINT Hydrogels: The Role of Nanoparticle Size and Ligand Density on Cell Association, Biodistribution, and Tumor Accumulation.Gold Nanoparticle Size and Shape Effects on Cellular Uptake and Intracellular Distribution of siRNA Nanoconstructs.The effect of nanoparticle size on in vivo pharmacokinetics and cellular interaction.Surface functionalization of polymeric nanoparticles for tumor drug delivery: approaches and challenges.Development and screening of a series of antibody-conjugated and silica-coated iron oxide nanoparticles for targeting the prostate-specific membrane antigen.Insight into the interactions between nanoparticles and cells.Mono and dually decorated nanoliposomes for brain targeting, in vitro and in vivo studies.Dual-targeting hybrid nanoparticles for the delivery of SN38 to Her2 and CD44 overexpressed human gastric cancer.Tumor-targeted Nanoparticle Delivery of HuR siRNA Inhibits Lung Tumor Growth In Vitro and In Vivo By Disrupting the Oncogenic Activity of the RNA-binding Protein HuR.Investigating in vitro and in vivo αvβ6 integrin receptor-targeting liposomal alendronate for combinatory γδ T cell immunotherapy.Nanocarrier Hydrodynamics and Binding in Targeted Drug Delivery: Challenges in Numerical Modeling and Experimental Validation.iRGD peptide conjugation potentiates intraperitoneal tumor delivery of paclitaxel with polymersomes.Chemodrug delivery using integrin-targeted PLGA-Chitosan nanoparticle for lung cancer therapy.Optimization and comparison of CD4-targeting lipid-polymer hybrid nanoparticles using different binding ligands.
P2860
Q26798467-1D0172C1-BD2C-46AA-8F62-C124F5AD897DQ27010317-24EB0C96-6E21-4AA9-A290-5657E075F434Q27011598-4B0ACEE7-4511-4007-A72B-CF3D965AD199Q27026630-4B3CEB74-9741-4336-9B18-3832936E5C30Q30832384-AC77B8E9-9E8D-4AB1-8AE9-5322C8C56E85Q34447986-78E0199E-FEE9-4356-8F14-E36F1CED46F2Q34609238-F4A4E0FE-7255-478F-AC81-645287587BA7Q35737878-F58ADB3B-6F63-421C-8A01-C10564D1F8D3Q35801347-CAFC28BC-538D-426D-B61F-7216945513A6Q35858739-C4D2F65A-46C4-428E-9196-1125DF473C38Q35912798-A2D241E1-E468-4899-8C68-0D8C830F6288Q36035550-515E27F1-BD15-4C3A-9F52-B2CF6B00DE73Q36395999-3792D75F-0A52-442D-9CA0-FDAAAEAC8776Q36447684-8218979D-4E1A-440E-B230-4DAF785BD572Q36721811-77B67BA2-B1F7-47F9-8425-BCA535369466Q37319230-F1F3339A-870B-4E9B-96F0-739171C4CB53Q37349428-BC01A01F-C02B-49FB-819F-65E8D0282FE5Q37613811-7D561F3A-39DC-423F-8718-2E8986DB2AD2Q37626377-78D7BAE0-D61D-4AB1-B7F5-66FDF61ED630Q37668409-A31DF2BF-21A9-4B43-873C-D614A9991EA9Q38148951-A376B0FB-9E45-4A58-8FB7-8C8D4DBF9EFEQ38149982-D7DB60BD-9A86-49BC-ADB8-368A4E936CFCQ38189490-4D6D72E7-14EA-44F0-BD06-9ED1238B7EFCQ38265617-168E213C-A903-41D0-B4F5-71A73BB188AAQ38598987-27E5DBF2-DE97-44FA-90FD-AE0E959D3662Q38636432-62210CC8-EECD-4753-8EA5-7866D7B83DDDQ38691793-1E51B5A4-EB7B-4E37-AC26-0CF36B3F5A26Q38701537-DC72F70F-6642-44B5-A768-AD8123DF97BEQ38784932-4DD3408E-B196-4307-89CB-F06D51DF0689Q38899902-B6EEB668-41B3-429A-87D3-7D6A4EBA2FB4Q39018873-F25D8B75-2205-4C61-B5CB-6C79ECF67C16Q39034160-35271C6C-2661-4373-BC4B-B8EC930178F1Q39043216-793F5F24-40E5-4558-A357-3EB216CA52CFQ39749680-D4DD8511-DCF3-4249-A6B5-CA8FB37635E4Q40176991-74F3B448-4F20-4F47-A097-AFB563117138Q41016131-94D7E130-2A94-4F25-9914-425E758DB805Q43096315-9A52133E-AF53-4435-A192-D60CD45C647FQ46505275-906BBAE0-D72D-4497-9B39-F30988799678Q47105106-AD7AF00F-0F1A-454A-9976-D8D79AC69C48Q47225568-86FB4394-0E0F-45EF-BFF3-94DAA97342F6
P2860
Effect of ligand density, receptor density, and nanoparticle size on cell targeting
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Effect of ligand density, receptor density, and nanoparticle size on cell targeting
@ast
Effect of ligand density, receptor density, and nanoparticle size on cell targeting
@en
type
label
Effect of ligand density, receptor density, and nanoparticle size on cell targeting
@ast
Effect of ligand density, receptor density, and nanoparticle size on cell targeting
@en
prefLabel
Effect of ligand density, receptor density, and nanoparticle size on cell targeting
@ast
Effect of ligand density, receptor density, and nanoparticle size on cell targeting
@en
P2860
P1476
Effect of ligand density, receptor density, and nanoparticle size on cell targeting
@en
P2093
Andrei Poloukhtine
Drew R Elias
P2860
P304
P356
10.1016/J.NANO.2012.05.015
P577
2012-06-09T00:00:00Z